Colgate Palmolive Co (CL) stock
CLNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 9/3034% above fair value
$97.90−0.10 (-0.10%)
Close on Nov 12, 2026Market cap $77.82BP/E 38.4Yield 2.12%
Colgate Palmolive r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was $366.00M, up 3.1% from the year before. Over ten years it grew 2.9% a year on average. The highest annual figure on record is $366.00M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $366.00M | +3.1% |
| FY2024 | Dec 31, 2024 | $355.00M | +3.5% |
| FY2023 | Dec 31, 2023 | $343.00M | +7.2% |
| FY2022 | Dec 31, 2022 | $320.00M | +4.2% |
| FY2021 | Dec 31, 2021 | $307.00M | +5.9% |
| FY2020 | Dec 31, 2020 | $290.00M | +3.2% |
| FY2019 | Dec 31, 2019 | $281.00M | +1.4% |
| FY2018 | Dec 31, 2018 | $277.00M | -2.8% |
| FY2017 | Dec 31, 2017 | $285.00M | -1.4% |
| FY2016 | Dec 31, 2016 | $289.00M | +5.5% |
| FY2015 | Dec 31, 2015 | $274.00M | -1.1% |
| FY2014 | Dec 31, 2014 | $277.00M | +3.7% |
| FY2013 | Dec 31, 2013 | $267.00M | +3.1% |
| FY2012 | Dec 31, 2012 | $259.00M | -1.1% |
| FY2011 | Dec 31, 2011 | $262.00M | +2.3% |
| FY2010 | Dec 31, 2010 | $256.00M | 0.0% |
| FY2009 | Dec 31, 2009 | $256.00M | +6.7% |
| FY2008 | Dec 31, 2008 | $240.00M | – |
See a number that looks wrong?